Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[The effect of the CYP7A1 A-278C promoter polymorphism on the progression of atherosclerosis, risk of a new clinical event and the influence of this variant on cholesterol-lowering therapy was investigated in 715 male patients with coronary atherosclerosis participating in REGRESS (Regression Growth Evaluation Statin Study).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP846350.RAcKfjjxs4iIMT4XGVVC6qp6mRJKdN_qRlU17Vo3osm_w130_assertion description "[The effect of the CYP7A1 A-278C promoter polymorphism on the progression of atherosclerosis, risk of a new clinical event and the influence of this variant on cholesterol-lowering therapy was investigated in 715 male patients with coronary atherosclerosis participating in REGRESS (Regression Growth Evaluation Statin Study).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP846350.RAcKfjjxs4iIMT4XGVVC6qp6mRJKdN_qRlU17Vo3osm_w130_provenance.
• assertion description "[The effect of the CYP7A1 A-278C promoter polymorphism on the progression of atherosclerosis, risk of a new clinical event and the influence of this variant on cholesterol-lowering therapy was investigated in 715 male patients with coronary atherosclerosis participating in REGRESS (Regression Growth Evaluation Statin Study).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP762940.RAaedweGNrilg3xeFxeOEeYcQSGuo-NsU0P1kiA3dhy20130_assertion description "[The effect of the CYP7A1 A-278C promoter polymorphism on the progression of atherosclerosis, risk of a new clinical event and the influence of this variant on cholesterol-lowering therapy was investigated in 715 male patients with coronary atherosclerosis participating in REGRESS (Regression Growth Evaluation Statin Study).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP762940.RAaedweGNrilg3xeFxeOEeYcQSGuo-NsU0P1kiA3dhy20130_provenance.
• NP54698.RAWSGjx1v9wFUPUCYa7guAngOiAL_pq3KxK9saQuh9BxA130_assertion description "[The effect of the CYP7A1 A-278C promoter polymorphism on the progression of atherosclerosis, risk of a new clinical event and the influence of this variant on cholesterol-lowering therapy was investigated in 715 male patients with coronary atherosclerosis participating in REGRESS (Regression Growth Evaluation Statin Study).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP54698.RAWSGjx1v9wFUPUCYa7guAngOiAL_pq3KxK9saQuh9BxA130_provenance.
• NP179367.RAK1GJC8j0yarr2yBVx79OES0_-k-y3AGWPA_H9PGmi1M130_assertion description "[The effect of the CYP7A1 A-278C promoter polymorphism on the progression of atherosclerosis, risk of a new clinical event and the influence of this variant on cholesterol-lowering therapy was investigated in 715 male patients with coronary atherosclerosis participating in REGRESS (Regression Growth Evaluation Statin Study).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP179367.RAK1GJC8j0yarr2yBVx79OES0_-k-y3AGWPA_H9PGmi1M130_provenance.
• NP859254.RA9dYhpkHrmiotWB3qmTM4Kr2TUniXv2PG9PtR0owG-xg130_assertion description "[The effect of the CYP7A1 A-278C promoter polymorphism on the progression of atherosclerosis, risk of a new clinical event and the influence of this variant on cholesterol-lowering therapy was investigated in 715 male patients with coronary atherosclerosis participating in REGRESS (Regression Growth Evaluation Statin Study).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP859254.RA9dYhpkHrmiotWB3qmTM4Kr2TUniXv2PG9PtR0owG-xg130_provenance.
• NP90603.RAaU7x1CUHwazEZGJiMtsIhf6wehV3rrNmWtqAnjT-SHI130_assertion description "[The effect of the CYP7A1 A-278C promoter polymorphism on the progression of atherosclerosis, risk of a new clinical event and the influence of this variant on cholesterol-lowering therapy was investigated in 715 male patients with coronary atherosclerosis participating in REGRESS (Regression Growth Evaluation Statin Study).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP90603.RAaU7x1CUHwazEZGJiMtsIhf6wehV3rrNmWtqAnjT-SHI130_provenance.
• NP480665.RARLFiLIeEb8lDqAYkge-9HSxECUCoy2jBfqg8JRmgcDc130_assertion description "[The effect of the CYP7A1 A-278C promoter polymorphism on the progression of atherosclerosis, risk of a new clinical event and the influence of this variant on cholesterol-lowering therapy was investigated in 715 male patients with coronary atherosclerosis participating in REGRESS (Regression Growth Evaluation Statin Study).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP480665.RARLFiLIeEb8lDqAYkge-9HSxECUCoy2jBfqg8JRmgcDc130_provenance.
• NP343935.RAm87ty8UEMTd1k-BGJc9QcDgMHipAp3VtP6t0Ce2GG48130_assertion description "[The effect of the CYP7A1 A-278C promoter polymorphism on the progression of atherosclerosis, risk of a new clinical event and the influence of this variant on cholesterol-lowering therapy was investigated in 715 male patients with coronary atherosclerosis participating in REGRESS (Regression Growth Evaluation Statin Study).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP343935.RAm87ty8UEMTd1k-BGJc9QcDgMHipAp3VtP6t0Ce2GG48130_provenance.
• NP343934.RAyEC57syWzrsM9vVw1gM1zjnvG7gP7YKIoNWr0Ixa1uo130_assertion description "[The effect of the CYP7A1 A-278C promoter polymorphism on the progression of atherosclerosis, risk of a new clinical event and the influence of this variant on cholesterol-lowering therapy was investigated in 715 male patients with coronary atherosclerosis participating in REGRESS (Regression Growth Evaluation Statin Study).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP343934.RAyEC57syWzrsM9vVw1gM1zjnvG7gP7YKIoNWr0Ixa1uo130_provenance.
• NP343952.RA97xVhKZUHiKYnRP_xm1KMMv8WCKp3KhshyDFKrKjgTE130_assertion description "[The effect of the CYP7A1 A-278C promoter polymorphism on the progression of atherosclerosis, risk of a new clinical event and the influence of this variant on cholesterol-lowering therapy was investigated in 715 male patients with coronary atherosclerosis participating in REGRESS (Regression Growth Evaluation Statin Study).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP343952.RA97xVhKZUHiKYnRP_xm1KMMv8WCKp3KhshyDFKrKjgTE130_provenance.
• NP344000.RAy5DFp7deAyGHf36y9SGhQVCqQo8gzPa28seRZQSYlzU130_assertion description "[The effect of the CYP7A1 A-278C promoter polymorphism on the progression of atherosclerosis, risk of a new clinical event and the influence of this variant on cholesterol-lowering therapy was investigated in 715 male patients with coronary atherosclerosis participating in REGRESS (Regression Growth Evaluation Statin Study).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP344000.RAy5DFp7deAyGHf36y9SGhQVCqQo8gzPa28seRZQSYlzU130_provenance.
• NP480666.RAJVbG9L9DjLbUyqlgbhGyQovMB8hXFr25GFiXmz6wodo130_assertion description "[The effect of the CYP7A1 A-278C promoter polymorphism on the progression of atherosclerosis, risk of a new clinical event and the influence of this variant on cholesterol-lowering therapy was investigated in 715 male patients with coronary atherosclerosis participating in REGRESS (Regression Growth Evaluation Statin Study).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP480666.RAJVbG9L9DjLbUyqlgbhGyQovMB8hXFr25GFiXmz6wodo130_provenance.
• NP480667.RAL-iPzRUbIQbzCf6YRBibFszv-4nSQCh1gBdAouo9ZpY130_assertion description "[The effect of the CYP7A1 A-278C promoter polymorphism on the progression of atherosclerosis, risk of a new clinical event and the influence of this variant on cholesterol-lowering therapy was investigated in 715 male patients with coronary atherosclerosis participating in REGRESS (Regression Growth Evaluation Statin Study).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP480667.RAL-iPzRUbIQbzCf6YRBibFszv-4nSQCh1gBdAouo9ZpY130_provenance.